botiss biomaterials GmbH
botiss biomaterials is an innovative, clinically and scientifically driven biotech company from Germany. Since the foundation of botiss biomaterials in 2009, we have become a leading developer, manufacturer and marketer of biomaterials for oral tissue regeneration. Our comprehensive range of high-quality, clinically proven solutions includes membranes for guided tissue and bone regeneration and soft tissue reconstruction, as well as a full range of bovine, allogeneic and synthetic bone substitute materials. The indication-oriented products are used worldwide in over 100 countries and are supported by both clinical studies and many years of clinical experience.
This is the driving force that leads us to a continuous development of new materials and to the optimization of established products.
botiss biomaterials invests in the development of innovative therapeutic concepts, patient-tailored products and regenerative measures to offer the best possible treatment options.
PATIENT’S SAFETY, EASE OF USE, RELIABLE AND PREDICTABLE TREATMENT RESULTS – THESE ARE YOUR AND OUR FIRST PRIORITIES.
Unique innovations, high-quality education, the close cooperation with practitioners and international research institutes continuously expand our product portfolio and the related more comfortable treatment options for users and patients themselves.
In order to achieve this, botiss biomaterials acts as a link between developers, researchers and clinicians, with a key focus on the everyday-practice experience.